36 Participants Needed

Finger Movement Training for Stroke

DG
MG
Overseen ByMohammad Ghassemi, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: North Carolina State University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Human development as a species has been strongly associated with the ability to dexterously manipulate objects and tools. Unfortunately, current therapy efforts typically fail to restore fine manual control after stroke. The goal of this study is to evaluate a new intervention that would combine targeted electrical stimulation of selected nerves with use a soft, pneumatically actuated hand exoskeleton to enhance repetitive practice of independent movements of the fingers and thumb in order to improve rehabilitation of hand function after stroke. The investigators will recruit stroke survivors in the subacute phase of recovery (2-18 months post-stroke). These participants will be involved in a 5-week intervention involving 15 training sessions. During these sessions, participants will train independent movement of the digits of the paretic hand. Evaluation of motor control of the paretic hand will occur prior to initiation of training, at the midpoint of the training period, after completion of training, and one month later.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Actuated Hand Exoskeleton, Soft, Pneumatically Actuated Hand Exoskeleton, Occupational Therapy, OT, Occupational Rehabilitation, Ergotherapy for stroke patients?

Research shows that robotic hand movement therapy, like HEXORR II, can improve hand function and reduce muscle tightness in stroke patients. Additionally, home-based therapy with devices like HandSOME II has been shown to improve hand movement and real-world use of the impaired limb, with benefits lasting for months.12345

Is finger movement training using hand exoskeletons safe for humans?

Research on various hand exoskeleton devices, including HandSOME II, HEXORR II, and RobHand, shows they are generally safe for use in humans, with no significant adverse events reported. Studies on healthy individuals and stroke patients found these devices comfortable and reliable, with no serious side effects.23678

How is the Actuated Hand Exoskeleton treatment different from other treatments for stroke rehabilitation?

The Actuated Hand Exoskeleton is unique because it uses soft, pneumatically controlled actuators to help stroke survivors extend their fingers, allowing for more natural hand movements. Unlike other devices, it is lightweight and conforms to the hand's shape, providing independent assistance to each finger while allowing full arm movement, which is crucial for effective rehabilitation.59101112

Eligibility Criteria

This trial is for stroke survivors who are 2-6 months post-stroke, can consent, see shapes on a screen, and have moderate to mild hand impairment without severe pain or joint issues that would prevent movement.

Inclusion Criteria

Moderate to mild hand impairment, as determined by a rating of Stage 4-6 on the Stage of Hand section of the Chedoke-McMaster Stroke Assessment
I understand the details of the trial and can agree to participate.
I had a stroke once, between 2-9 months ago.
See 1 more

Exclusion Criteria

I have been diagnosed with hemispatial neglect.
I have stiff joints in my arms that limit their movement.
My shoulder pain in my weaker arm is not severe.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo a 5-week intervention involving 15 training sessions to improve hand function using targeted electrical stimulation and a hand exoskeleton

5 weeks
15 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with evaluations occurring at the midpoint, after completion, and one month later

4 weeks
3 visits (in-person)

Treatment Details

Interventions

  • Actuated Hand Exoskeleton
  • Occupational Therapy
Trial Overview The study tests a new therapy combining electrical nerve stimulation with a soft hand exoskeleton (AVK system) to improve finger movement. Participants will undergo 15 training sessions over 5 weeks with evaluations before, during, after training, and one month later.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Functional electrical stimulation (FES) + AVK groupExperimental Treatment1 Intervention
This group will use the AVK system in combination with targeted FES to provide training of independent movement of each digit of the paretic hand. This training has two modes: Key Combination and Song. In the Key Combination mode, the subject will attempt to play the discrete key or key combinations specified on the computer screen to practice difficult movements and combinations. In the Song mode, sequential, rhythmic movements will be practiced as the participant is guided to play a series of keys, specified as falling keys, constituting five-note songs. Key Combination will be employed at the beginning and end of each training session to practice discrete movements that proved troubling during the current or previous session. Most of the session will be spent in the Song mode to emphasize the transitions from one movement to the next. In both modes the AVK system will trigger FES for the finger matching the desired key and signal the PneuGlove to resist movement of other digits.
Group II: OT GroupActive Control1 Intervention
An occupational therapist will provide therapy of matching duration to the OT subject group. This will consist of 10 minutes of stretching of the finger muscles, particularly of the extrinsic finger flexors. This stretching will be followed by two 20-minute sessions of therapy focused on active task practice, object manipulation, and individuated movement of the digits. The Canadian Occupational Performance Measure (COPM) will be administered to identify goals that incorporate dexterous use of the paretic hand. Part of each training session will be used to practice these tasks, while the remainder will be used to practice component skills. Active practice will be followed by a final 10 minutes of stretching of muscles of the digits.

Find a Clinic Near You

Who Is Running the Clinical Trial?

North Carolina State University

Lead Sponsor

Trials
38
Recruited
50,000+

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator

Trials
2,103
Recruited
2,760,000+

Findings from Research

The FingerBot, a novel actuated exoskeleton for the index finger, was tested on 10 stroke survivors and showed that constant extension torque assistance significantly increased the workspace area and active range of motion compared to spring-like assistance.
Using the FingerBot, participants demonstrated improved accuracy in reaching targets with constant extension torque assistance, highlighting its potential as a valuable tool for hand rehabilitation after stroke.
Use of a novel robotic interface to study finger motor control.Cruz, EG., Kamper, DG.[2016]
In a clinical trial involving 15 individuals with chronic stroke, the modified robotic device HEXORR II significantly improved hand function, as evidenced by increased Fugl-Meyer scores and reduced flexor hypertonia after 12 or 24 therapy sessions.
While the robotic therapy enhanced finger movement and range of motion, it did not lead to improvements in overall functional tasks, suggesting that future studies should integrate the device with more practical hand activities.
Pilot test of dosage effects in HEXORR II for robotic hand movement therapy in individuals with chronic stroke.Chen, J., Black, I., Nichols, D., et al.[2022]
The HandSOME II wearable hand exoskeleton significantly improved functional ability and real-world use of the impaired limb in 10 chronic stroke patients after 8 weeks of home use, with benefits retained at a 3-month follow-up.
The device not only enhanced physical performance, as shown by improved range of motion and hand displacement during tasks, but also appeared to promote brain reorganization, indicating its potential to support motor recovery through neuroplasticity.
Home-Based Therapy After Stroke Using the Hand Spring Operated Movement Enhancer (HandSOME II).Casas, R., Sandison, M., Nichols, D., et al.[2023]

References

Use of a novel robotic interface to study finger motor control. [2016]
Pilot test of dosage effects in HEXORR II for robotic hand movement therapy in individuals with chronic stroke. [2022]
Home-Based Therapy After Stroke Using the Hand Spring Operated Movement Enhancer (HandSOME II). [2023]
Walking faster and farther with a soft robotic exosuit: Implications for post-stroke gait assistance and rehabilitation. [2022]
Soft Robotic Bilateral Hand Rehabilitation System for Fine Motor Learning. [2020]
Novel knit fabric rehabilitation equipment for finger impairment. [2022]
Initial Testing of Robotic Exoskeleton Hand Device for Stroke Rehabilitation. [2023]
Hand rehabilitation based on the RobHand exoskeleton in stroke patients: A case series study. [2023]
A pneumatic glove and immersive virtual reality environment for hand rehabilitative training after stroke. [2017]
A soft neuroprosthetic hand providing simultaneous myoelectric control and tactile feedback. [2023]
A Preliminary Study to Design and Evaluate Pneumatically Controlled Soft Robotic Actuators for a Repetitive Hand Rehabilitation Task. [2022]
12.United Statespubmed.ncbi.nlm.nih.gov
High Compliance Pneumatic Actuators to Promote Finger Extension in Stroke Survivors. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security